Annual CAPEX
$126.28 M
-$1.89 M-1.48%
31 December 2022
Summary:
Horizon Therapeutics Public Limited annual capital expenditures is currently $126.28 million, with the most recent change of -$1.89 million (-1.48%) on 31 December 2022. During the last 3 years, it has fallen by -$73.58 million (-36.82%).HZNP CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$18.47 M
-$20.66 M-52.81%
30 June 2023
Summary:
Horizon Therapeutics Public Limited quarterly capital expenditures is currently $18.47 million, with the most recent change of -$20.66 million (-52.81%) on 30 June 2023.HZNP Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$134.52 M
+$8.31 M+6.59%
30 June 2023
Summary:
Horizon Therapeutics Public Limited TTM capital expenditures is currently $134.52 million, with the most recent change of +$8.31 million (+6.59%) on 30 June 2023.HZNP TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HZNP CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -36.8% | -75.0% | -22.1% |
| 5 y5 years | +652.9% | +313.4% | +784.1% |
HZNP CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -36.8% | -84.5% | -32.7% |
Horizon Therapeutics Public Limited CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $18.47 M(-52.8%) | $134.52 M(+6.6%) |
| Mar 2023 | - | $39.13 M(-16.9%) | $126.21 M(-0.1%) |
| Dec 2022 | $126.28 M(-1.5%) | $47.11 M(+58.0%) | $126.28 M(+24.9%) |
| Sept 2022 | - | $29.82 M(+193.6%) | $101.14 M(-30.4%) |
| June 2022 | - | $10.15 M(-74.1%) | $145.26 M(-2.5%) |
| Mar 2022 | - | $39.20 M(+78.4%) | $149.03 M(+16.3%) |
| Dec 2021 | $128.17 M(-35.9%) | $21.97 M(-70.3%) | $128.17 M(-25.8%) |
| Sept 2021 | - | $73.94 M(+431.1%) | $172.65 M(+54.0%) |
| June 2021 | - | $13.92 M(-24.1%) | $112.14 M(+13.1%) |
| Mar 2021 | - | $18.33 M(-72.4%) | $99.18 M(-50.4%) |
| Dec 2020 | $199.85 M(+1019.2%) | $66.45 M(+394.8%) | $199.85 M(+42.8%) |
| Sept 2020 | - | $13.43 M(+1290.2%) | $139.93 M(+6.8%) |
| June 2020 | - | $966.00 K(-99.2%) | $130.97 M(-3.0%) |
| Mar 2020 | - | $119.00 M(+1721.9%) | $135.01 M(+656.1%) |
| Dec 2019 | $17.86 M(+6.5%) | $6.53 M(+46.2%) | $17.86 M(+17.4%) |
| Sept 2019 | - | $4.47 M(-10.8%) | $15.21 M(+40.0%) |
| June 2019 | - | $5.01 M(+170.9%) | $10.87 M(+82.5%) |
| Mar 2019 | - | $1.85 M(-52.5%) | $5.96 M(-64.5%) |
| Dec 2018 | $16.77 M(+286.8%) | $3.89 M(+3168.9%) | $16.77 M(+27.2%) |
| Sept 2018 | - | $119.00 K(+22.7%) | $13.19 M(-8.9%) |
| June 2018 | - | $97.00 K(-99.2%) | $14.47 M(-7.1%) |
| Mar 2018 | - | $12.66 M(+4012.0%) | $15.58 M(+259.3%) |
| Dec 2017 | $4.34 M(-72.4%) | $308.00 K(-78.0%) | $4.34 M(-15.6%) |
| Sept 2017 | - | $1.40 M(+16.4%) | $5.14 M(-7.9%) |
| June 2017 | - | $1.20 M(-15.4%) | $5.58 M(-42.1%) |
| Mar 2017 | - | $1.42 M(+28.3%) | $9.62 M(-38.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $15.72 M(+119.7%) | $1.11 M(-39.7%) | $15.72 M(-8.9%) |
| Sept 2016 | - | $1.84 M(-65.0%) | $17.26 M(-2.2%) |
| June 2016 | - | $5.25 M(-30.2%) | $17.65 M(+34.7%) |
| Mar 2016 | - | $7.53 M(+184.8%) | $13.10 M(+83.1%) |
| Dec 2015 | $7.16 M(+104.5%) | $2.64 M(+18.3%) | $7.16 M(+15.8%) |
| Sept 2015 | - | $2.23 M(+217.2%) | $6.18 M(+30.2%) |
| June 2015 | - | $704.00 K(-55.4%) | $4.74 M(+3.5%) |
| Mar 2015 | - | $1.58 M(-5.2%) | $4.58 M(+30.9%) |
| Dec 2014 | $3.50 M(+192.2%) | $1.66 M(+107.9%) | $3.50 M(+46.3%) |
| Sept 2014 | - | $800.00 K(+47.3%) | $2.39 M(+26.6%) |
| June 2014 | - | $543.00 K(+9.9%) | $1.89 M(+28.8%) |
| Mar 2014 | - | $494.00 K(-11.0%) | $1.47 M(+22.5%) |
| Dec 2013 | $1.20 M(-10.3%) | $555.00 K(+86.2%) | $1.20 M(+23.9%) |
| Sept 2013 | - | $298.00 K(+148.3%) | $967.00 K(+51.6%) |
| June 2013 | - | $120.00 K(-46.7%) | $638.00 K(-55.3%) |
| Mar 2013 | - | $225.00 K(-30.6%) | $1.43 M(+6.9%) |
| Dec 2012 | $1.34 M(-16.7%) | $324.00 K(-1145.2%) | $1.34 M(-38.3%) |
| Sept 2012 | - | -$31.00 K(-103.4%) | $2.17 M(-17.0%) |
| June 2012 | - | $910.00 K(+584.2%) | $2.61 M(+54.0%) |
| Mar 2012 | - | $133.00 K(-88.5%) | $1.70 M(+5.7%) |
| Dec 2011 | $1.60 M(+124.6%) | $1.16 M(+179.7%) | $1.60 M(+168.7%) |
| Sept 2011 | - | $413.00 K(-8360.0%) | $597.00 K(+106.6%) |
| June 2011 | - | -$5000.00(-112.2%) | $289.00 K(-61.4%) |
| Mar 2011 | - | $41.00 K(-72.3%) | $749.00 K(+5.8%) |
| Dec 2010 | $714.00 K | $148.00 K(+41.0%) | $708.00 K(+26.4%) |
| Sept 2010 | - | $105.00 K(-76.9%) | $560.00 K(+23.1%) |
| June 2010 | - | $455.00 K | $455.00 K |
FAQ
- What is Horizon Therapeutics Public Limited annual capital expenditures?
- What is the all time high annual CAPEX for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited TTM capital expenditures?
- What is the all time high TTM CAPEX for Horizon Therapeutics Public Limited?
What is Horizon Therapeutics Public Limited annual capital expenditures?
The current annual CAPEX of HZNP is $126.28 M
What is the all time high annual CAPEX for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high annual capital expenditures is $199.85 M
What is Horizon Therapeutics Public Limited quarterly capital expenditures?
The current quarterly CAPEX of HZNP is $18.47 M
What is the all time high quarterly CAPEX for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high quarterly capital expenditures is $119.00 M
What is Horizon Therapeutics Public Limited TTM capital expenditures?
The current TTM CAPEX of HZNP is $134.52 M
What is the all time high TTM CAPEX for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high TTM capital expenditures is $199.85 M